Publications:  Dr Jessica Okosun

Araf S, Wang J, Ashton-Key M, Korfi K, Di Bella D, Rio-Machin A, Odabashian M, Foria V et al.(2019). Transmission of diffuse large B-cell lymphoma by an allogeneic stem-cell transplant. Haematologica vol. 104, (4) e174-e177.

Araf S, Wang J, Korfi K, Pangault C, Kotsiou E, Rio-Machin A, Rahim T, Heward J et al.(2019). Correction: Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma. Leukemia

Okosun J, Kridel R, Fitzgibbon J(2018). Rituximab as a first step in tackling transformation. Lancet Haematol vol. 5, (8) e326-e327.

Heward JA, Kumar EA, Korfi K, Okosun J, Fitzgibbon J(2018). Precision medicine and lymphoma. Curr Opin Hematol vol. 25, (4) 329-334.

Araf S, Wang J, Korfi K, Pangault C, Kotsiou E, Rio-Machin A, Rahim T, Heward J et al.(2018). Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma. Leukemia vol. 32, (5) 1261-1265.

Araf S, Okosun J, Fitzgibbon J(2018). Predicting early relapse in follicular lymphoma: have we turned a corner?. Lancet Oncol vol. 19, (4) 441-442.

Horton SJ, Giotopoulos G, Yun H, Vohra S, Sheppard O, Bashford-Rogers R, Rashid M, Clipson A et al. (2017). Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors. Nat Cell Biol. vol. 19, 1093-1104.

Mansouri L, Noerenberg D, Young E, Mylonas E, Abdulla M, Frick M, Asmar F, Ljungström V et al.(2016). Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma. Blood vol. 128, (23) 2666-2670.

Kotsiou E, Okosun J, Besley C, Iqbal S, Matthews J, Fitzgibbon J, Gribben J, DAVIES JK(2016). TNFRSF14 aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses. Blood vol. 128, (1) 72-81.

Okosun J, Montoto S, Fitzgibbon J(2016). The routes for transformation of follicular lymphoma. Current Opinion in Hematology vol. 23, (4) 1-1.

Okosun J, Wolfson RL, Wang J, Araf S, Wilkins L, Castellano BM, Escudero-Ibarz L, Al Seraihi AF et al.(2016). Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma. Nature Genetics vol. 48, (2) 183-188.

Araf S, Okosun J, Koniali L, Fitzgibbon J, Heward J(2016). Epigenetic dysregulation in follicular lymphoma. Epigenomics vol. 8, (1) 77-84.

Okosun J, Cwynarski K(2015). Non-Hodgkin Lymphoma: High Grade. Postgraduate Haematology: Seventh Edition,

Tawana K, Wang J, Renneville A, Bödör C, Hills R, Loveday C, Savic A, Van Delft FW et al.(2015). Disease evolution and outcomes in familial AML with germline CEBPA mutations. Blood vol. 126, (10) 1214-1223.

Okosun J, Packham G, Fitzgibbon J(2014). Investigational epigenetically targeted drugs in early phase trials for the treatment of haematological malignancies. Expert Opin Investig Drugs vol. 23, (10) 1321-1332.

Okosun J, Bödör C, Wang J, Araf S, Yang CY, Pan C, Boller S, Cittaro D et al.(2014). Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. Nature Genetics vol. 46, (2) 176-181.

Okosun J, Bödör C, Wang J, Araf S, Yang C-Y, Pan C, Boller S, Cittaro D et al.(2014). Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. Nat Genet vol. 46, (2) 176-181.

Bödör C, Grossmann V, Popov N, Okosun J, O'Riain C, Tan K, Marzec J, Araf S et al.(2013). EZH2 mutations are frequent and represent an early event in follicular lymphoma. Blood vol. 122, (18) 3165-3168.

Montoto S, Shaw K, Okosun J, Gandhi S, Fields P, Wilson A, Shanyinde M, Cwynarski K et al.(2012). HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era. J Clin Oncol vol. 30, (33) 4111-4116.

Okosun J, Warbey V, Shaw K, Montoto S, Fields P, Marcus R, Virchis A, McNamara C et al.(2012). Interim fluoro-2-deoxy-D-glucose-PET predicts response and progression-free survival in patients with Hodgkin lymphoma and HIV infection. AIDS vol. 26, (7) 861-865.

Okosun J, Bödör C, Smith M(2011). Myelodysplastic syndrome: 2011 and beyond. Br J Nurs vol. 20, (22)

Okosun J, Fitzgibbon J(2011). It's a targeted world in non-Hodgkin's lymphoma. Br J Nurs vol. 20, (17)

Okosun J, Fitzgibbon J(2011). It's a targeted world in non-Hodgkin's lymphoma. British Journal of Nursing vol. 20, (17 SUPPL.)

Okosun J, McNamara C(2011). Paraneoplastic peripheral blood eosinophilia in relapsed follicular lymphoma. Leuk Lymphoma vol. 52, (2) 328-330.